Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate

Clinical and Experimental Dermatology

Volumn 26, Issue 1, 2001, Pages 27-29

  Kirby, B ^a   Marsland, A M ^a   Carmichael, A J ^b   Griffiths, C E M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; CYTOKINE; EMOLLIENT AGENT; ETRETIN; ETRETINATE; HYDROXYUREA; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CASE REPORT; DELAYED HYPERSENSITIVITY; DRUG SAFETY; HUMAN; KIDNEY DISEASE; MALE; PRIORITY JOURNAL; PSORIASIS; PUVA;

ADULT; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; DERMATOLOGIC AGENTS; DRUG THERAPY, COMBINATION; HUMANS; MALE; METHOTREXATE; PSORIASIS; RECURRENCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0035094721     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.2001.00753.x     Document Type: Article

References (10)

1. The majority of epidermal T cells in psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: A type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients
2. Elevated turnout necrosis factor-alpha (TNF-alpha) biological acivity in psoriatic skin lesions
3. Cytokine blockade as a new strategy to treat rheumatoid arthritis: Inhibition of tumor necrosis factor
4. Introduction: Anti-TNF strategies in the treatment of Crohn's disease
5. Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: A randomised phase III trial
6. Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions
7. Severe psoriasis - Oral therapy with a new retinoid
8. The Salford Psoriasis Index: An holistic measure of psoriasis severity
9. Etanercept in the treatment of psoriatic arthritis
10. Safety of infliximab in clinical trials